Linkedin-in

Investor Relations

Lipocine is a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery. 

NASDAQLPCN
YearTrailing 12-MonthsCalendar Year 2026Calendar Year 2025Calendar Year 2024Calendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2011
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Proxy & Information StatementsOther
FormDescriptionDateFormat
S-3/APre-effective amendment to an S-3 filingNov 17, 2017Open Pre-effective amendment to an S-3 filing in HTML.Open Pre-effective amendment to an S-3 filing in DOC file.Open Pre-effective amendment to an S-3 filing in PDF file.Open Pre-effective amendment to an S-3 filing in XLS file.
S-3Simplified registration formOct 13, 2017Open Simplified registration form in HTML.Open Simplified registration form in DOC file.Open Simplified registration form in PDF file.Open Simplified registration form in XLS file.
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Mar 6, 2017Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in HTML.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in DOC file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in PDF file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in XLS file.

Innovating beyond boundaries for patients

Krista Fogarty phone: (801) 994-7383 email: kf@lipocine.com